INDOCOBSEIndoco Remedies Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Fri, 15 May, 2026 · 11:57 IST

The Company hereby regrets to inform about the sad demise of Dr. Anand Nadkarni (DIN : 06881461) Non Executive Director of the Company today i.e. Friday, 15th May, 2026.

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹224.90
prior close
₹229.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.4%+0.4% vs market
Pharmaceuticals peers, median of 160sector-0.2%+0.2% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.6
10m
-0.1
15m
-0.1
30m
-0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0-0.4+0.4-0.2+0.2
Next day
-4.4-1.7-2.7-0.9-3.5
2d
-5.1-1.3-3.8-0.2-4.8
3d
-6.4-0.7-5.7+0.3-6.7
4d
-8.9+0.4-9.3+1.1-10.0
5d
-11.1+0.5-11.6+0.2-11.3
1w
-14.6+2.8-17.4+1.0-15.6
15d
-11.8+1.2-13.0-0.2-11.6
1m
+6.6+5.3+1.3+1.5+5.2
2m
+11.0+9.9+1.1+7.7+3.3
3m
-3.0+13.1-16.1+8.1-11.2
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indoco Remedies Ltd has announced the death of Dr. Anand Nadkarni, who served as a Non-Executive Director of the company (DIN: 06881461). The demise occurred on Friday, 15th May, 2026. The company described his association as having immensely benefited the company and called his passing an irreparable loss. The disclosure was made under SEBI Regulation 30 (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company expressed deep sympathy and condolences to his family from all directors and employees.

Likely market impact

The death of a board director may raise concerns about board composition and governance continuity, though as a Non-Executive Director, the operational impact on the company is likely minimal. Market reaction will depend on investor perception of the director's significance to the board.